|Quantity Discounts||1 - 2|
|3 - 4|
|5 - 6|
|7 - 9|
|10 - 9999|
FDA’s Work Plan ... the 21st Century Cures Act ... and You: Disruptive? Absolutely. But ... How Much?
The 21st Century Cures Act is a mega-complex set of compromises that Congress mandated. Right now, behind closed doors, the FDA is figuring out how to implement it.
Every FDA-regulated health sciences company will be affected. That means you.
Just in time, FDAnews has stepped into the knowledge vacuum with legal and regulatory counsel from the attorney the Supreme Court hailed as “the expert” on medical-device law.
In 90 fast-paced minutes, Prof. Jim O’Reilly Esq. of the University of Cincinnati College of Law will reveal current FDA thinking and touch on the gut issues affecting makers of drugs, devices and biologics ... operators of clinical trials ... and every other health science company under FDA jurisdiction. Expect this presentation to help you:
Why spend literally thousands of dollars per hour bringing Mr. O’Reilly to your organization for a sit-down when it’s so easy — and inexpensive too get up to speed on this critically important change in FDA regulation? Order now.
Jim O’Reilly Esq. teaches food and drug law at the University of Cincinnati College of Law. The author of 53 texts and 215 articles, he was quoted in a 2000 Supreme Court ruling as “the expert” on medical-device law. He chairs the FDA Committee of the American Bar Association; serves on the Editorial Advisory Board of FDLI’s Food and Drug Law Journal; and is the longtime program chair of FDLI conferences.
Copyright ©2019. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing